A phase one trial of a multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone in collaboration with The University of Manchester and Manchester University NHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback